Global Hormonal Contraceptive Market Size, Trends, and Growth Opportunity, By Product (Oral Contraceptives, Skin Patches, Intrauterine Devices, Hormonal Implants, and Others), By Hormone (Progestin Only, and Combined Hormone Contraceptives), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), By Region and Forecast to 2030.
Global Hormonal Contraceptive Market
The Global Hormonal Contraceptive Market was valued at USD 18.46 billion in 2022 and is expected to expand to USD 24.65 billion by 2030, at a CAGR of 3.11% during the forecast period 2023-2030.
Hormonal contraceptive refers to birth control methods that act on the endocrine system. Nearly all methods are composed of steroid hormones, but in India, one selective estrogen receptor modulator is marketed as a contraceptive. Hormonal contraceptives contain progesterone, estrogen, and progesterone only. However, these do not protect against HIV and other sexually transmitted infections (STIs).
Market Drivers
The increasing focus on family planning and the need for preventing unwanted pregnancies is the key factor driving the growth of the global hormonal contraceptive market. The growth is attributed to certain health diseases related to teenage pregnancies, growing awareness about modern contraception methods, and the rising use of oral pills as a key factor in preventing unplanned pregnancy, which propels the market growth.
Furthermore, favorable government regulations and advancements in hormonal contraception are actively affecting the growth of the market.
Market Restraints
The availability of substitute contraceptive methods, some health risks related to the usage of contraceptives, and lack of social approval are expected to restrain the hormonal contraceptive market growth in the future. Also, limited availability to contraceptives declines the revenue of the market.
Market Segmentation
The global hormonal contraceptive market is segmented into product, hormone, distribution channel, and region.
Based on the product, the global hormonal contraceptive market is segmented into oral contraceptives, skin patches, intrauterine devices, hormonal implants, and others.
Further, based on distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and others.
Regional Analysis
The global hormonal contraceptive market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the global hormonal contraceptive market in 2023, accounting for the highest revenue share, and is anticipated to maintain this trend throughout the forecast period, due to the high approval of hormonal contraceptives, well-established healthcare facilities, and presence of key market vendors in the region.
The Asia-Pacific region is expected to grow significantly, due to rising healthcare expenditure focusing on women's health as a priority. Also, the raise in investments by major players and strong economic growth are expected to propel the growth of the market in the region.
Key Players
Various key players are discussed in the global hormonal contraceptive market report including; Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., and Others.
For instance, in December 2021, Cooper Surgical, Inc. acquired Generate Life Sciences for $1.6 billion. This acquisition enhances the reproductive segment of Cooper Surgical, Inc. Generate Life Sciences is a provider of donor eggs & sperm for fertility treatments, new-born stem cell storage, and fertility cryopreservation services.
Market Taxonomy
By Product
• Oral Contraceptives
• Skin Patches
• Intrauterine Devices
• Hormonal Implants
• Other
By Hormone
• Progestin Only
• Combined Hormone Contraceptives
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Hormonal Contraceptive Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Hormonal Contraceptive Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Hormonal Contraceptive Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Hormonal Contraceptive Market Share Analysis, By Product
5.3 Global Hormonal Contraceptive Market Size and Forecast, By Product
5.3.1 Oral Contraceptives
5.3.2 Skin Patches
5.3.3 Intrauterine Devices
5.3.4 Hormonal Implants
5.3.5 Other
6 Global Hormonal Contraceptive Market, By Hormone
6.1 Y-o-Y Growth Comparison, By Hormone
6.2 Global Hormonal Contraceptive Market Share Analysis, By Hormone
6.3 Global Hormonal Contraceptive Market Size and Forecast, By Hormone
6.3.1 Progestin Only
6.3.2 Combined Hormone Contraceptives
7 Global Hormonal Contraceptive Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Hormonal Contraceptive Market Share Analysis, By Distribution Channel
7.3 Global Hormonal Contraceptive Market Size and Forecast, By Distribution Channel
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Others
8 Global Hormonal Contraceptive Market, By Region
8.1 Global Hormonal Contraceptive Market Share Analysis, By Region
8.2 Global Hormonal Contraceptive Market Share Analysis, By Region
8.3 Global Hormonal Contraceptive Market Size and Forecast, By Region
9 North America Hormonal Contraceptive Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Hormonal Contraceptive Market Share Analysis, By Product
9.3 North America Hormonal Contraceptive Market Share Analysis, By Hormone
9.4 North America Hormonal Contraceptive Market Size and Forecast, By Distribution Channel
9.5 North America Hormonal Contraceptive Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Hormonal Contraceptive Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Hormonal Contraceptive Market Share Analysis, By Product
10.3 Europe Hormonal Contraceptive Market Share Analysis, By Hormone
10.4 Europe Hormonal Contraceptive Market Size and Forecast, By Distribution Channel
10.5 Europe Hormonal Contraceptive Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Hormonal Contraceptive Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Hormonal Contraceptive Market Share Analysis, By Product
11.3 Asia Pacific Hormonal Contraceptive Market Share Analysis, By Hormone
11.4 Asia Pacific Hormonal Contraceptive Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Hormonal Contraceptive Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Hormonal Contraceptive Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Hormonal Contraceptive Market Share Analysis, By Product
12.3 Latin America Hormonal Contraceptive Market Share Analysis, By Hormone
12.4 Latin America Hormonal Contraceptive Market Size and Forecast, By Distribution Channel
12.5 Latin America Hormonal Contraceptive Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Hormonal Contraceptive Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Hormonal Contraceptive Market Share Analysis, By Product
13.3 Middle East Hormonal Contraceptive Market Share Analysis, By Hormone
13.4 Middle East Hormonal Contraceptive Market Size and Forecast, By Distribution Channel
13.5 Middle East Hormonal Contraceptive Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Female Health Company
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Teva Pharmaceutical Industries Limited
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.25 Key Market Developments
15.2.6 Key Strategies
15.3 Bayer AG
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Pfizer, Inc.
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Mylan N.V
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Johnson & Johnson
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Ansell LTD.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Mayer Laboratories
15. 8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Merck & Co., Inc.
15.9.1 Overview
15.9.2 Offerings
15.4.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Church & Dwight, Co., Inc.
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
